Session Will Discuss Causes of Infections and Ways to Prevent Them
Newswise — SAN ANTONIO – RyMed Technologies (Franklin, Tenn.) will host a breakfast symposium on the origin of catheter-related bloodstream infections (CRBSIs) and how to prevent them at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA).
The interactive session is titled “Misfits in the Mix: Fibrin, Biofilm, and CRBSI.” It is intended to raise clinicians’ awareness about the interaction between fibrin, biofilm, and CRBSI, and also provide tools for minimizing or eliminating this potentially fatal disease process.
The symposium, which includes a complimentary breakfast, will be held Wednesday, October 17th from 7:00 am to 8:30 am in Convention Center Room 103 A & B. The AVA meeting will be held October 16-19 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
The speakers who will present during the session include:
* Sivaprasad Sukavaneshvar, President and CEO of Thrombodyne, Inc., who will discuss the science connecting fibrin, biofilm, and CRBSIs.
* Stephen Harris, RN, Vice President of Education for Carolina Wellness Group, who will suggest practical approaches to preventing CRBSIs by minimizing biofilm formation and fibrin adhesion.
* Brenda Caillouet, RN, who will relate clinical outcomes that have resulted from understanding the science behind biofilm formation and fibrin adhesion and applying it to central line protocol choices.
RyMed Technologies will be at Booth 118 in the Exhibit Hall of the Henry B. Gonzalez Convention Center.
Resources:
Text:* Q & A with symposium speaker Brenda Caillouet, RN on the role of the IV needleless connector in preventing occlusions with cancer patients
* Article by William Jarvis, M.D. on choosing the appropriate IV connector type to minimize bloodstream infection risk
* Article on appropriate central line practices and devices to reduce CRBSI risk caused by biofilm formation
Video:* IV Connector Virtual Tour
About RyMed Technologies, Inc. Founded in 1994, RyMed Technologies, Inc. specializes in the development and marketing of innovative safety products in the field of intravenous catheter care management. The company's products are designed to help reduce catheter occlusions, catheter-related infections, and biofilm development commonly associated with vascular access devices. More than 10 years of research and development have gone into the InVision-Plus product line. Numerous studies regarding the efficacy of the InVision-Plus Needleless IV Connector have been published in the last six years-which is particularly important in light of the growing incidence of central line associated bloodstream infections (CLABSI). For more information on the product and published studies, access www.rymedtech.com or call (615) 790-8093. The company is headquartered in Franklin, Tenn.
RSS